Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Peter Steen Jensen

30 indexed publications match this author name.

ORCID: 0000-0001-7058-6930
OpenAlex: https://openalex.org/A5028671809

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 14 Clinical Trial 12 Brain Imaging 8 Aging 8 Observational Study 7 Pharmacology 7 Safety 6 Mechanism of Action 6 Wellbeing 5 Headache / Migraine 5 Addiction 5 Depression 5

Journals

bioRxiv 3 ClinicalTrials.gov 2 Headache 2 medRxiv 2 PsyArXiv 2 PLOS One 1 Journal of Psychopharmacology 1 Digital Commons - Gardner-Webb University (Gardner-Webb University) 1

Publication history

Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”PLOS One · 2026-06-30 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29 The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.ClinicalTrials.gov · 2026-03-24 Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01 Psilocybin Treatment for Refractory Depression: A Clinical ReviewDigital Commons - Gardner-Webb University (Gardner-Webb University) · 2026-01-01 Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-18 The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.ACS pharmacology & translational science · 2025-06-13 Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention.Journal of psychoactive drugs · 2025-01-01 Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label StudyResearch Square · 2024-08-23 Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility StudyClinicalTrials.gov · 2024-07-12 Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.Journal of medicinal chemistry · 2024-05-09 The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-22 Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2024-01-01 CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01 Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.Molecular psychiatry · 2023-09-01 Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-18 The use of classic psychedelics among adults: a Danish online survey study.Nordic journal of psychiatry · 2023-05-01 Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).BMJ open · 2022-10-14 Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivitymedRxiv · 2022-07-10 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of psychopharmacology (Oxford, England) · 2022-01-01 Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Frontiers in pharmacology · 2022-01-01 A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive EffectsPsyArXiv · 2021-12-14 A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive EffectsPsyArXiv · 2021-12-14 P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsEuropean Neuropsychopharmacology · 2021-12-01 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsbioRxiv · 2021-01-29 DARK Classics in Chemical Neuroscience: NBOMes.ACS chemical neuroscience · 2020-12-02 Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.Human psychopharmacology · 2012-07-01 Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens.Planta medica · 2006-06-01 Psilocin, Bufotenine and Serotonin: Historical and Biosynthetic ObservationsJournal of Psychedelic Drugs · 1979-01-01 Biosynthesis of psilocybin. II. Incorporation of labelled tryptamine derivatives.Acta chemica Scandinavica · 1968-01-01

Author directory